Advanced

Induction chemotherapy and post-remission imatinib therapy for de Novo BCR-ABL-positive AML

Lazarevic, Vladimir LU ; Golovleva, Irina ; Nygren, Ida and Wahlin, Anders (2006) In American Journal of Hematology 81(6). p.1-470
Please use this url to cite or link to this publication:
author
; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Aged, Antineoplastic Agents, Benzamides, Fusion Proteins, bcr-abl, Humans, Imatinib Mesylate, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Male, Piperazines, Pyrimidines, Remission Induction
in
American Journal of Hematology
volume
81
issue
6
pages
2 pages
publisher
John Wiley and Sons Inc.
external identifiers
  • scopus:33646860812
  • pmid:16680752
ISSN
0361-8609
DOI
10.1002/ajh.20578
language
English
LU publication?
yes
id
0e0c00ce-d055-4bc0-bb55-c955e7150ab1
date added to LUP
2016-05-24 17:21:18
date last changed
2020-03-24 05:08:31
@article{0e0c00ce-d055-4bc0-bb55-c955e7150ab1,
  author       = {Lazarevic, Vladimir and Golovleva, Irina and Nygren, Ida and Wahlin, Anders},
  issn         = {0361-8609},
  language     = {eng},
  number       = {6},
  pages        = {1--470},
  publisher    = {John Wiley and Sons Inc.},
  series       = {American Journal of Hematology},
  title        = {Induction chemotherapy and post-remission imatinib therapy for de Novo BCR-ABL-positive AML},
  url          = {http://dx.doi.org/10.1002/ajh.20578},
  doi          = {10.1002/ajh.20578},
  volume       = {81},
  year         = {2006},
}